The Cross-Border Biotech Blog

Website | RSS | Twitter

"Biotechnology, health and business in Canada, the United States and worldwide."

Author: Jeremy Grushcow is a corporate lawyer at Ogilvy Renault in Toronto; Dani Peters is a consultant at Fabiani & Company in Washington, D.C.; Richard Chan is a science consultant at R&D Funding Management in Mississauga, Ontario, Canada; Peter van der Velden is the President and CEO of Lumira Capital in Toronto, and Beni Rovinski is Lumira Capital's managing director.

Related Categories: Health Law | Science & Technology Law | International | North America | Canada

Recent Posts from The Cross-Border Biotech Blog